Toronto Dominion Bank
CLLS

Toronto Dominion Bank’s Cellectis CLLS Stock Holding History

Toronto Dominion Bank’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31
Closed -$58 – 1206
2024
Q2 		$58 Hold
31
– – ﹤0.01% 1388
2024
Q1 		$82 Hold
31
– – ﹤0.01% 1345
2023
Q4 		$95 Hold
31
– – ﹤0.01% 1464
2023
Q3 		$49 Hold
31
– – ﹤0.01% 1744
2023
Q2 		$0 Hold
31
– – ﹤0.01% 1530
2023
Q1 		$0 Buy
+31
New +$78 ﹤0.01% 1470
2022
Q3 		– Sell
-31
Closed – – 1566
2022
Q2 		$0 Buy
+31
New +$109 ﹤0.01% 1407

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Toronto Dominion Bank's CLLS Position: Q3 2024 in Review

Toronto Dominion Bank sold out of Cellectis (CLLS) in Q3 2024, closing a stake of 31 shares — an estimated $58 sold.

Toronto Dominion Bank first reported a position in CLLS in Q2 2022 and held it in 7 quarters. The position peaked at $95 in Q4 2023. 27 funds tracked by Wall St. Rank hold CLLS as of Q3 2024.

  • Toronto Dominion Bank reported no remaining Cellectis position as of Q3 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 31 Cellectis shares in Q3 2024, an estimated $58.
  • Toronto Dominion Bank first reported a position in Cellectis in Q2 2022 and held it in 7 quarters.
  • Toronto Dominion Bank's Cellectis position peaked at $95 in Q4 2023.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.